BLISSGVSPharmaceuticals
Bliss GVS Pharma Ltd — PE Ratio & Valuation Analysis
₹215.59
-3.69%
Current P/E15.00xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E28.2x46.9% below avg
✅
52.8% Discount to Industry
BLISSGVS P/E 15.00x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹7.95 | ₹163 | 20.6x |
| 2024 | ₹7.11 | ₹165 | 23.2x |
| 2023 | ₹6.72 | ₹125 | 18.5x |
| 2022 | ₹1.43 | ₹72 | 50.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Bliss GVS Pharma Ltd Valuation
Bliss GVS Pharma Ltd (BLISSGVS) currently trades at 15.00x earnings. The Pharmaceuticals sector average PE is 31.77x. BLISSGVS is trading at a discount to peers — may indicate relative value. Historically, BLISSGVS has traded at an average PE of 28.2x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
8.36%
Dividend Yield
0.32%
More on Bliss GVS Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.